Burosumab for the Treatment of Tumor‐Induced Osteomalacia-Reference-Cited by-同舟云学术

Burosumab for the Treatment of Tumor‐Induced Osteomalacia

Published:2021-01-12 Issue:4 Volume:36 Page:627-635
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Jan de Beur Suzanne M¹,Miller Paul D²,Weber Thomas J³,Peacock Munro⁴,Insogna Karl⁵^ORCID,Kumar Rajiv⁶,Rauch Frank⁷,Luca Diana⁸,Cimms Tricia⁸,Roberts Mary Scott⁸,San Martin Javier⁸,Carpenter Thomas O⁵

Affiliation:

1. Johns Hopkins University School of Medicine Baltimore MD USA

2. Colorado Center for Bone Research Lakewood CO USA

3. Duke University Durham NC USA

4. Indiana University School of Medicine Indianapolis IN USA

5. Yale University School of Medicine New Haven CT USA

6. Mayo Clinic College of Medicine Rochester MN USA

7. McGill University Montreal Canada

8. Ultragenyx Pharmaceutical Inc. Novato CA USA

Funder

Ultragenyx Pharmaceutical

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.4233

Reference30 articles.

1. Tumour-induced osteomalacia

2. Tumor localization and biochemical response to cure in tumor-induced osteomalacia

3. Sensitivity of Fibroblast Growth Factor 23 Measurements in Tumor-Induced Osteomalacia

4. Burosumab: First Global Approval

5. Efficacy and safety of burosumab in children aged 1–4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inherited phosphate and pyrophosphate disorders;The Journal of the American Dental Association;2024-08

2. Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study;Osteoporosis International;2024-07-01

3. Refractory Hypophosphatemia as a Clue to Recurrent Malignancy;The American Journal of Medicine;2024-07

4. Healthcare Resource Use Associated With Tumor-Induced Osteomalacia: A Literature Review;The Journal of Clinical Endocrinology & Metabolism;2024-06-24

5. Tumor-induced osteomalacia: A systematic literature review;Bone Reports;2024-06